8,610
Total Claims
$1.1M
Drug Cost
601
Beneficiaries
$1,825
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-88%
Opioid rate vs peers
0.3% vs 2.6% avg
+71%
Cost per patient vs peers
$1,825 vs $1,068 avg
+64%
Brand preference vs peers
14.8% vs 9.0% avg
Opioid Prescribing
0.3%
Opioid Rate
27
Opioid Claims
$523
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
85% generic
Brand: 1,262 claims · $943K
Generic: 7,282 claims · $150K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 149 | $128K |
| Semaglutide | 103 | $102K |
| Dulaglutide | 77 | $94K |
| Fluticasone/Umeclidin/Vilanter | 84 | $68K |
| Rivaroxaban | 50 | $66K |
| Mepolizumab | 12 | $45K |
| Empagliflozin | 38 | $45K |
| Mirabegron | 23 | $24K |
| Insulin Glargine,hum.Rec.Anlog | 30 | $22K |
| Tirzepatide | 15 | $21K |
| Linagliptin | 12 | $20K |
| Insulin Degludec | 20 | $16K |
| Fluticasone/Vilanterol | 30 | $16K |
| Atogepant | 12 | $13K |
| Evolocumab | 14 | $13K |
Prescribing Profile
Patient Profile
73
Avg Age
49%
Female
1.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data